Lynette BowmanVice President, Human Resources

Ms. Bowman has served as Vice President, Human Resources at Pacira since its inception. She has almost 20 years of experience as an HR professional, with most of her management experience coming from the pharmaceutical and healthcare industries in both small entrepreneurial start-ups and large global organizations.

Ms. Bowman transitioned from the VP of HR position she held at SkyePharma, Inc. since 2003. Prior to joining SkyePharma, Ms. Bowman held HR director positions at other San Diego companies including Women First Healthcare, Inc., Anacomp, Inc., Comprehensive Health Center, and Builder Brothers, Inc.

Ms. Bowman has an MBA with an emphasis in human resources from National University and a BA in interdisciplinary studies and liberal arts from the University of California, Davis and National University.

Ronald Burch, MD, Ph.D.Chief Medical Officer

Dr. Burch joined our company as Chief Medical Officer in June 2007. Dr. Burch has worked within the pharmaceutical industry for the past 20 years in various aspects of discovery research, drug development, and product assessment and planning.

Before joining Pacira, Dr. Burch held CEO, consultant, and Scientific Advisory Board member roles at Cure Therapeutics, Inc., where Dr. Burch raised financing and developed the regulatory strategy. From 2001 through 2005, Dr. Burch served as President and CEO of AlgoRx Pharmaceuticals, Inc., a company developing therapeutic agents for pain management where he led three successful financing rounds. From 1997-2001, Dr. Burch was VP, Scientific Evaluations and Immunotherapeutics. Dr. Burch also held director positions at Purdue Pharma LP, Zeneca Pharmaceuticals Group, Rhone-Poulenc Rorer Inc. (now Sanofi-Aventis), and Nova Pharmaceutical Corp.

Ron serves as Board Chairman of Biowave Corporation, with devices for intractable pain, and as a member on the Scientific Advisory Boards of KAI Pharmaceuticals and Connecticut Innovations.

There are over 200 publications that bear Dr. Burch’s name. While at the National Institute of Mental Health from 1987-1991, Dr. Burch was able to explore receptor regulation with Julius Axelrod, Nobel Laureate.

He received both his MD and PhD in pharmacology from the Medical University of South Carolina. Dr. Burch holds BS degrees in chemistry and marine biology from the College of Charleston.

William Kirkpatrick, Ph.D.Vice President, Compliance

Dr. Bill Kirkpatrick joined Pacira as Vice President of Compliance in June 2008. He brings 30 years experience in medical regulatory and quality matters to the position. Recently, as an independent contractor, Dr. Kirkpatrick provided consulting services to Amgen, Santen Ophthalmics and Abraxis.

Prior to developing a consulting practice Bill served as Vice President Regulatory and Quality for Artes medical where he managed the approval process for the company’s implantable soft tissue bulking agent. As Director of Regulatory Affairs for Molecular Biosystems Inc., Bill coordinated U.S. and EU approval process for the ultrasound contrast agent, Optison. The product approval process involved intensive interactions with FDA Drug (CDER) and Device (CDRH) branches and, after two successful advisory panel meetings culminated in product approval in 1997. As Senior Regulatory Consultant for Parexel International, Bill helped a number of domestic and international clients achieve product approvals and establish good manufacturing practice (GMP) compliance. He has served in management positions with major corporations including Baxter/AHSC, Chiron Ophthalmics, IMS and ICN Pharmaceuticals.

Dr. Kirkpatrick holds a doctorate in pharmacology from the University of California at Los Angeles and a professional degree in pharmacy.

William Lambert, Ph.D.Senior Vice President, Pharmaceutical Development

Dr. Lambert, with over 20 years of drug development experience, has served as our Senior VP, Pharmaceutical Development since the company’s inception. He is responsible for R&D and intellectual property management related to injectable controlled release dosage forms for traditional and protein therapeutics.

Dr. Lambert served as Senior VP Pharmaceutical Development, when he joined SkyePharma in January 2006. Prior to 2006, Dr. Lambert held director positions at Eisai Inc., in drug delivery technology and pharmaceutical and analytical R&D, for almost a decade. Prior to Eisai, Dr. Lambert worked at Pfizer Inc. and The Upjohn Company (now Pfizer Inc.) as a research investigator with increasing levels of responsibility.

Dr. Lambert is on the advisory council for the National Institute for Pharmaceutical Technology and Education and on the advisory boards of the Journal of Pharmaceutical Sciences and the Handbook of Pharmaceutical Excipients. He is well published and is an inventor on two drug delivery patents.

Dr. Lambert received his Ph.D. in pharmaceutics from the University of Utah and his BS in pharmacy from the University of Rhode Island.

Taunia Markvicka, Pharm.D.Vice President of Marketing

Taunia Markvicka joined Pacira as VP of Marketing in February 2008. She brings with her more than 15 years of experience in pharmaceutical marketing, new product planning/business analysis, and market research. In addition, Dr Markvicka held clinical pharmacy positions in both private and academic medical centers.

Dr. Markvicka is a partner at Stack Pharmaceuticals, Inc., a commercialization, marketing, and strategy firm, in addition to her role at Pacira.

Her most recent pharmaceutical positions include serving as a franchise marketing director at The Medicines Company for the cardiovascular and hematology acute care products. Before this, Dr. Markvicka was Marketing Director at Watson Pharmaceuticals, where she oversaw marketing, medical marketing and new product planning for urology and general products, as well as leadership positions in women's health and dermatology. She was also with Advantage Healthcare, a strategic marketing and new product planning firm, as a Vice President for two years. She joined the pharmaceutical industry, initially taking a two year post-doctoral fellowship position with Sandoz (now Novartis).

Dr. Markvicka holds a Doctor of Pharmacy degree from the University of Nebraska, an MBA from St. Josephs University, and she maintains her license as a registered pharmacist.

Fred RyanVice President of Business and Commercial Development

Fred Ryan joined Pacira in February 2008 as Vice President of Business and Commercial Development. Mr. Ryan brings to Pacira over two decades of experience in the pharmaceutical industry.

Prior to joining Pacira Mr. Ryan was a founding partner of Stack Pharmaceuticals, Inc., a healthcare consulting firm specializing in developing commercial and business strategies for emerging healthcare companies, venture capital and private equity organizations. Mr. Ryan will maintain his partner role at Stack. In addition to his founding and consulting roles at Stack, Mr. Ryan was also the founder and President of Global Pharma Solutions LLC, a healthcare consulting company.

Mr. Ryan was with The Medicines Company between 2000 and 2005. During his tenure he was VP of Corporate and Business Development, a member of the Executive Committee and a Corporate Officer focusing on licensing and commercial partnerships.

Prior to join the Medicines Company he spent 15 years with Novartis. From 1998 -2000 he was Executive Director Commercial Development and Operations for Novartis Pharmaceuticals in the US. He also served as a Director of Strategic Planning for Novartis Pharmaceuticals in the US during 1997.

Prior to the Sandoz/ Ciba merger he was with Ciba Pharmaceuticals in the US 1992-1996 and also with Ciba Consumer Pharmaceuticals 1985-1992. During his tenure with Ciba he held senior positions in Financial Operations, Business Analysis and Business Development/Licensing.

Mr. Ryan received his MBA from Fairleigh Dickinson University and his undergraduate degree in business from Bryant University.

James ScibettaChief Financial Officer

James Scibetta, BS, MBA, joined Pacira as the Chief Financial Officer in August 2008. Mr. Scibetta brings more than 20 years of financial leadership experience in private and public companies as well as investment banking to Pacira. Most recently he has been instrumental in leading several financial transactions for Genzyme Corporation (NASDAQ: GENZ), Nephros, Inc. (AMEX: NEP), Bioenvision Inc. (NASDAQ: BIVN) and Merrimack Pharmaceuticals Inc. Mr. Scibetta remains a Member of the Board of Directors for Labopharm Inc. (NASDAQ: DDSS) and Nephros Inc. (Amex: NEP). Prior to his specialty pharmaceutical company tenures, Mr. Scibetta held senior investment banking positions where he was responsible for sourcing and executing transactions for a broad base of public and private technology-based healthcare companies encompassing businesses of biotechnology, pharmacy benefits management, CRO, health and wellness benefits management, disease management, evidenced-based medicine. Mr. Scibetta received his Bachelor of Science in Physics from Wake Forest University and a Masters of Business Administration from the University of Michigan.

David St. PeterVice President, Medical Education and Scientific Affairs

David St. Peter, MD joined Pacira as Vice President of Medical Education and Scientific Affairs in August of 2008. Dr. St. Peter has been a leader in the healthcare, pharmaceutical and medical device industries for the past 18 years. He has experience in professional and consumer healthcare marketing, as well as early drug commercialization and market development strategies. Dr. St. Peter was at inVentiv Health where he held several senior management positions since 2001, most recently serving on their executive team as president of The Selva Group, a medical education and event management company. In addition to industry positions at Marion Merrel Dow and Merck, Sharp & Dohme, he was in private practice for 2 years and continues to see patients in the acute care setting as a Hospitalist. Dr. St. Peter brings a clear understanding of the critical elements required for successful late-phase market and KOL development in the institutional setting. Dr. St. Peter holds an M.D. from Kansas University Medical Center and a B.S from the University of Kansas. Dr. St. Peter completed an internship in surgery at the University of Missouri and St. Lukes Hospital and a residency in medicine at Baptist Medical Center.

Mark WaltersSenior Vice President, Technical Operations and Business Development

Mr. Walters has served as Senior Vice President, Technical Operations and Business Development for Pacira since its inception. Mr. Walters has over 30 years of pharmaceutical experience, with executive positions in operations, business development, marketing and sales.

Prior to Pacira, Mr. Walters was with the drug delivery company, SkyePharma Inc., for seven years, as VP of Commercial Development and as director of both strategic sourcing and product management. Before SkyePharma, he was at Alliance Pharmaceutical Corp. for 12 years and worked as Program Director, Project Director and Product Director in the imaging and liquid ventilation areas. Prior to Alliance, he had sales management positions with Whitehall Laboratories (a division of American Home Products) and William H. Rorer (now Aventis).

Mr. Walters’ has received six patents in the fields of imaging and ventilatory support.

Mr. Walters received his BA in biology from Hamilton College.